Failed rescue therapy with rapamycin after paraquat intoxication

Clinical Toxicology

Volumn 48, Issue 1, 2010, Pages 84-86

  Lorenzen, Johan Matthes ^a   Schonenberger, Eva ^a   Hafer, Carsten ^a   Hoeper, Marius ^a   Kielstein, Jan T ^a  

^a HANNOVER MEDICAL SCHOOL   (Germany)

Author keywords

Acute renal failure; Fatal; Hemodialysis; Intoxication; Paraquat

Indexed keywords

METHYLPREDNISOLONE; PARAQUAT; RAPAMYCIN;

ADULT; ARTICLE; CASE REPORT; DIALYSIS; DISEASE SEVERITY; HUMAN; LUNG FIBROSIS; MALE; MORTALITY; PARAQUAT POISONING; PREDICTION; RESPIRATORY FAILURE; SUICIDE ATTEMPT; TERTIARY HEALTH CARE; TREATMENT FAILURE;

ANTI-INFLAMMATORY AGENTS; ANTIOXIDANTS; DIALYSIS; FATAL OUTCOME; HERBICIDES; HUMANS; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; MALE; METHYLPREDNISOLONE; MIDDLE AGED; OXYGEN INHALATION THERAPY; PARAQUAT; PROTEIN-SERINE-THREONINE KINASES; PULMONARY FIBROSIS; REACTIVE OXYGEN SPECIES; RESPIRATORY INSUFFICIENCY; SIROLIMUS; SUICIDE; TREATMENT FAILURE;

EID: 76749138945     PISSN: 15563650     EISSN: 15569519     Source Type: Journal    
DOI: 10.3109/15563650903376089     Document Type: Article

References (11)

1. Kim SJ, Gil HW, Yang JO, Lee EY, Hong SY. The clinical features of acute kidney injury in patients with acute paraquat intoxication. Nephrol Dial Transplant 2009; 24:1226-1232.
2. Snider GL. Interstitial pulmonary fibrosis-which cell is the culprit? Am Rev Respir Dis 1983; 127:535-539.
3. Lin JL, Lin-Tan DT, Chen KH, Huang WH. Repeated pulse of methylprednisolone and cyclophosphamide with continuous dexamethasone therapy for patients with severe paraquat poisoning. Crit Care Med 2006; 34:368-373.
4. Gunawardena G, Roberts DM, Buckley NA. Randomized control trial of immunosuppression in paraquat poisoning. Crit Care Med 2007; 35:330-331.
5. Barrueto F, Lee C, Pajoumand M, Yeung SY, Starr PE. Use of sirolimus in a case of severe paraquat poisoning. Clin Toxicol (Phila) 2008; 46:778-779.
6. Hart TB, Nevitt A, Whitehead A. A new statistical approach to the prognostic significance of plasma paraquat concentrations. Lancet 1984; 2:1222-1223.
7. Stenton SB, Partovi N, Ensom MH. Sirolimus: the evidence for clinical pharmacokinetic monitoring. Clin Pharmacokinet 2005; 44: 769-786.
8. Sehgal SN, Baker H, Vezina C. Rapamycin (AY-22,989), a new antifungal antibiotic. II. Fermentation, isolation and characterization. J Antibiot (Tokyo) 1975; 28:727-732.
9. Vezina C, Kudelski A, Sehgal SN. Rapamycin (AY-22,989), a new antifungal antibiotic. I. Taxonomy of the producing streptomycete and isolation of the active principle. J Antibiot (Tokyo) 1975; 28:721-726.
10. Terada N, Lucas JJ, Szepesi A, Franklin RA, Domenico J, Gelfand EW. Rapamycin blocks cell cycle progression of activated T cells prior to events characteristic of the middle to late G1 phase of the cycle. J Cell Physiol 1993; 154:7-15.
11. Simler NR, Howell DC, Marshall RP, Goldsack NR, Hasleton PS, Laurent GJ, Chambers RC, Egan JJ. The rapamycin analogue SDZ RAD attenuates bleomycin-induced pulmonary fibrosis in rats. Eur Respir J 2002; 19:1124-1127.